Menopause Digital Hormone Balancing App Market Report 2025

The menopause digital hormone balancing app market size has grown rapidly in recent years. It will grow from $1.3 billion in 2024 to $1.52 billion in 2025 at a compound annual growth rate (CAGR) of 17.4%. The growth observed during the historic period can be linked to increasing interest in holistic wellness practices, wider availability of telehealth services, growing endorsement from healthcare professionals, stronger focus on preventive healthcare, and the implementation of data privacy regulations.

The menopause digital hormone balancing app market size is expected to see rapid growth in the next few years. It will grow to $2.86 billion in 2029 at a compound annual growth rate (CAGR) of 17.1%. The growth projected for the forecast period can be attributed to rising awareness of hormonal health, increasing smartphone adoption, higher demand for personalized health management, greater societal recognition of menopause as a natural stage, and the growing prevalence of menopausal symptoms. Key trends during the forecast period include advancements in predictive analytics for symptom management, innovations in gamified health and wellness features, integration of menopause care into broader digital health platforms, development of natural language chatbots for tailored support, and the expansion of community-driven virtual support networks.

The growing use of smartphones is expected to drive the expansion of the menopause digital hormone balancing app market. Smartphone penetration refers to the proportion of people who own or actively use a smartphone, and its rise is mainly due to the increasing affordability of these devices, making them accessible to a larger population. With more people using smartphones, menopause digital hormone balancing apps can reach a wider audience, allowing more women to access symptom tracking, hormone monitoring, lifestyle tips, and educational content conveniently on their devices. For example, a report by Uswitch Limited in February 2023 stated that the UK saw 71.8 million mobile connections in 2022, marking a 3.8% increase from 2021. By 2025, it is projected that 95% of the 68.3 million people living in the UK will own smartphones. As smartphone penetration increases, the demand for menopause digital hormone balancing apps is also growing.

Companies in the menopause digital hormone balancing app market are focusing on technological innovations, such as AI-powered apps, to offer personalized hormone management, symptom tracking, and lifestyle recommendations, thereby enhancing women’s health and well-being. AI-powered apps use artificial intelligence to analyze users' health data and deliver customized advice, symptom management, and support tailored to the individual’s menopausal journey. For instance, in July 2022, Lisa Health Inc., a digital health company based in the U.S., launched the Midday app, which provides personalized guidance and resources for women experiencing menopausal symptoms. The app offers tailored insights, symptom tracking, expert medical advice, and educational content, all backed by Mayo Clinic’s expertise. Midday helps bridge the gap in menopause care by providing timely interventions that improve women's health and quality of life during this crucial life stage.

In January 2024, Dr. Reddy's Laboratories Ltd., a pharmaceutical company based in India, acquired MenoLabs LLC, a U.S.-based women’s health company that offers a menopause digital hormone balancing app. This acquisition will allow Dr. Reddy’s Laboratories to strengthen its presence in the fast-growing women’s nutritional and wellness markets and complement its U.S. self-care and wellness business by addressing the growing demand for science-based products that help manage menopause symptoms.

Major players in the menopause digital hormone balancing app market are Chorus Health Inc., Noom Inc., Maven Clinic Co., Forth Ltd., Join Olivia AB, Clue by BioWink GmbH, Balance App Ltd., Peppy Health Ltd., Elektra Health Inc., Eli Health Inc., FemTech Health Inc., Health and Her Ltd., Hormona Ltd., Lisa Health Inc., Mira Fertility Inc., Oova Life Inc., Stella LLC, Vira Health Ltd., Wild AI Ltd., and Gennev Inc.

North America was the largest region in the menopause digital hormone balancing app market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in menopause digital hormone balancing app report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the menopause digital hormone balancing app market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

A menopause digital hormone balancing app is a technology platform designed to support individuals through the hormonal changes experienced during menopause. It typically offers features for tracking symptoms, monitoring health trends, and delivering personalized guidance based on user-specific data. The app leverages technology to provide customized insights and support, often incorporating educational resources and lifestyle recommendations to promote overall health and well-being.

The primary types of menopause digital hormone balancing apps include symptom tracking, hormone monitoring, lifestyle management, educational apps, and others. Symptom tracking involves recording and observing health changes over time to recognize patterns and manage conditions effectively. These apps are available on platforms such as iOS, Android, and web-based systems, and are offered through various subscription models including free, paid, and freemium options. The main end users include women, healthcare professionals, clinics, and other related groups.

The menopause digital hormone balancing app market research report is one of a series of new reports that provides menopause digital hormone balancing app market statistics, including menopause digital hormone balancing app industry global market size, regional shares, competitors with a menopause digital hormone balancing app market share, detailed menopause digital hormone balancing app market segments, market trends and opportunities, and any further data you may need to thrive in the menopause digital hormone balancing app industry. This menopause digital hormone balancing app market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The menopause digital hormone balancing app market includes revenues earned by entities by providing services such as mood and sleep tracking, medication guidance, lifestyle coaching, and menstrual cycle tracking. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.